Patents by Inventor Thomas Høeg-Jensen

Thomas Høeg-Jensen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9260501
    Abstract: Insulins to which there is connected an amino acid oligomer have satisfactory properties.
    Type: Grant
    Filed: October 29, 2007
    Date of Patent: February 16, 2016
    Assignee: Novo Nordisk A/S
    Inventors: Thomas Høeg-Jensen, Thomas Børglum Kjeldsen, Jan Markussen
  • Patent number: 8710000
    Abstract: The present invention relates to novel human insulin derivatives which are soluble at physiological pH values and have a prolonged profile of action. The invention also relates to pharmaceutical compositions containing such derivatives and to methods of treating diabetes and hyperglycaemia using the insulin derivatives of the invention.
    Type: Grant
    Filed: November 7, 2008
    Date of Patent: April 29, 2014
    Assignee: Novo Nordisk A/S
    Inventors: Patrick William Garibay, Thomas Høeg-Jensen
  • Publication number: 20100279931
    Abstract: The present invention relates to novel human insulin derivatives which are soluble at physiological pH values and have a prolonged profile of action. The invention also relates to pharmaceutical compositions containing such derivatives and to methods of treating diabetes and hyperglycaemia using the insulin derivatives of the invention.
    Type: Application
    Filed: November 7, 2008
    Publication date: November 4, 2010
    Inventors: Patrick William Garibay, Thomas Høeg-Jensen
  • Publication number: 20100069605
    Abstract: Insulins to which there is connected an amino acid oligomer have satisfactory properties.
    Type: Application
    Filed: October 29, 2007
    Publication date: March 18, 2010
    Applicant: Novo Nordisk A/S
    Inventors: Thomas Høeg-Jensen, Thomas Børglum Kjeldsen, Jan Markussen
  • Patent number: 6451762
    Abstract: The present invention relates-to protracted acting, water-soluble aggregates of derivatives of human insulin, derivatives of human insulin capable of forming such aggregates, pharmaceutical compositions containing them, and to the use of such aggregates in the treatment of diabetes.
    Type: Grant
    Filed: January 8, 1999
    Date of Patent: September 17, 2002
    Assignee: Novo Nordisk A/S
    Inventors: Svend Havelund, Ib Jonassen, Per Balschmidt, Thomas Høeg-Jensen